Mental health advocacy and Pharmaceuticals

One Person’s Journey from Celebrity Medical Model Advocate to Skeptic: An Interview with Rose Cartwright

Mad in America

NOVEMBER 6, 2024

I realized that I was mistaken about a lot of my assumptions about what we know about mental health. We know much less about the brain than a lot of people in the mental health advocacy space realize. You write that you worry about how psychedelics are getting co-opted by pharmaceutical industries.

Trauma and the brain

Trauma and the brain Poverty and mental health Psychedelic therapy Childhood trauma

“All Real Living Is Meeting”: Brent Robbins on Love, Death, and the Possibilities of Psychology

Mad in America

FEBRUARY 12, 2025

Thats not a leap people often makefrom philosophical psychology to critiques of the pharmaceutical industry and medicalization. She was deeply involved in critical psychiatry and critiques of the pharmaceutical industry. Karter: Well come back to phenomenology and theory, but I want to ask about your connection to critical psychiatry.

Genetics and mental health

Genetics and mental health Aging and mental health Trauma and the brain Mental health advocacy

Mental Health Clinicians

One Person’s Journey from Celebrity Medical Model Advocate to Skeptic: An Interview with Rose Cartwright

“All Real Living Is Meeting”: Brent Robbins on Love, Death, and the Possibilities of Psychology

Stay Connected